Mariner Wealth Advisors (Cincinnati)’s Repros Therapeutics Inc. RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-11,000
Closed -$7K 294
2017
Q4
$7K Hold
11,000
﹤0.01% 275
2017
Q3
$4K Hold
11,000
﹤0.01% 274
2017
Q2
$5K Hold
11,000
﹤0.01% 253
2017
Q1
$13K Hold
11,000
﹤0.01% 244
2016
Q4
$15K Hold
11,000
﹤0.01% 238
2016
Q3
$23K Hold
11,000
﹤0.01% 249
2016
Q2
$18K Hold
11,000
﹤0.01% 248
2016
Q1
$11K Hold
11,000
﹤0.01% 239
2015
Q4
$13K Buy
+11,000
New +$35.3K ﹤0.01% 243

Mariner Wealth Advisors (Cincinnati)'s RPRX Position: Q1 2018 in Review

Mariner Wealth Advisors (Cincinnati) sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 11,000 shares — an estimated $7K sold.

Mariner Wealth Advisors (Cincinnati) first reported a position in RPRX in Q4 2015 and held it in 9 quarters. The position peaked at $23K in Q3 2016. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Mariner Wealth Advisors (Cincinnati) reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Mariner Wealth Advisors (Cincinnati) sold 11,000 Repros Therapeutics Inc. shares in Q1 2018, an estimated $7K.
  • Mariner Wealth Advisors (Cincinnati) first reported a position in Repros Therapeutics Inc. in Q4 2015 and held it in 9 quarters.
  • Mariner Wealth Advisors (Cincinnati)'s Repros Therapeutics Inc. position peaked at $23K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q1 2018, filed 15 May 2018.